Chlorpheniramine Maleate; Codeine Phosphate Patent Expiration

1. Tuxarin Er patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6383471 MAINPOINTE Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
Apr, 2019

(5 years ago)

US6248363 MAINPOINTE Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
Nov, 2019

(4 years ago)

US9066942 MAINPOINTE Oral dosage forms for oxygen-containing active agents and oxyl-containing polymer
Jan, 2032

(7 years from now)

US9107921 MAINPOINTE Oral dosage forms for oxygen containing active agents and oxyl-containing polymers
Jan, 2032

(7 years from now)




Market Authorisation Date: 22 June, 2015

Treatment: Treatment of cough and symptoms associated with upper respiratory allergies or a common cold with codeine phosphate and chlorpheniramine maleate orally administered extended release tablets

Dosage: TABLET, EXTENDED RELEASE

More Information on Dosage

TUXARIN ER family patents

Family Patents